By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. (XTLB.TA)

TLV Market Data in ILA, Fundamentals in USD
ILA 4.50
-ILA 0.20
-4.26%
Last Update: 11 Sept 2025, 14:04
ILA 39.66M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
ILA 3.90 - ILA 10.00
52 Week Range

XTLB.TA Stock Price Chart

Explore XTL Biopharmaceuticals Ltd. interactive price chart. Choose custom timeframes to analyze XTLB.TA price movements and trends.

XTLB.TA Company Profile

Discover essential business fundamentals and corporate details for XTL Biopharmaceuticals Ltd. (XTLB.TA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

30 Aug 2005

Employees

10.00

CEO

Noam Band

Description

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

XTLB.TA Financial Timeline

Browse a chronological timeline of XTL Biopharmaceuticals Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 31 Dec 2024

EPS came in at -ILA 0.00 , while revenue for the quarter reached ILA 1.64M .

Earnings released on 30 Sept 2024

EPS came in at -ILA 0.00 , while revenue for the quarter reached ILA 613.40K .

Earnings released on 30 Jun 2024

EPS came in at -ILA 0.00 .

Earnings released on 30 Apr 2024

EPS came in at ILA 0.00 .

Earnings released on 29 Mar 2024

Earnings released on 5 Mar 2024

EPS came in at -ILA 0.00 .

Earnings released on 30 Jun 2023

EPS came in at -ILA 0.00 .

Earnings released on 31 Mar 2023

EPS came in at -ILA 0.01 .

Earnings released on 22 Mar 2023

EPS came in at -ILA 0.01 .

Earnings released on 31 Dec 2022

EPS came in at -ILA 0.00 .

Earnings released on 30 Jun 2022

EPS came in at -ILA 0.00 .

Earnings released on 31 Mar 2022

EPS came in at ILA 0.00 .

Earnings released on 31 Dec 2021

EPS came in at ILA 0.01 .

Earnings released on 30 Sept 2021

EPS came in at -ILA 0.00 .

Earnings released on 30 Jun 2021

EPS came in at -ILA 0.01 .

Earnings released on 31 Mar 2021

EPS came in at ILA 0.00 .

Earnings released on 31 Dec 2020

EPS came in at ILA 0.00 .

Earnings released on 30 Sept 2020

EPS came in at -ILA 0.00 .

XTLB.TA Stock Performance

Access detailed XTLB.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run